PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $68,000 | -66.8% | 17,931 | -59.4% | 0.00% | -50.0% |
| Q1 2019 | $205,000 | +272.7% | 44,136 | +239.7% | 0.00% | – |
| Q4 2018 | $55,000 | -48.6% | 12,992 | -10.6% | 0.00% | -100.0% |
| Q3 2017 | $107,000 | +50.7% | 14,530 | +38.7% | 0.00% | 0.0% |
| Q2 2017 | $71,000 | -69.5% | 10,473 | -61.1% | 0.00% | -50.0% |
| Q4 2016 | $233,000 | +150.5% | 26,951 | +65.6% | 0.00% | +100.0% |
| Q3 2015 | $93,000 | -38.0% | 16,278 | -55.7% | 0.00% | 0.0% |
| Q1 2014 | $150,000 | +78.6% | 36,759 | +120.5% | 0.00% | – |
| Q3 2013 | $84,000 | – | 16,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|